Latest Medtech News
Medtronic is the largest medical device company in the world, and it rarely goes a month without an exciting advancement: a tuck-in acquisition, a new FDA clearance, a leadership change, or a shift in strategy. For anyone hiring into the MedTech space, competing against Medtronic, or trying to keep a pulse on the industry's biggest player, keeping track of all of it in one place is useful. That's what this page is for.
We update this tracker regularly with Medtronic's most relevant recent activity: acquisitions, product launches, regulatory milestones, and leadership moves. Plus we cast a look back at the deals and decisions that shaped the company over the past decade.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Medtronic in 2026: What's Happened So Far
Medtronic and Karl Storz Expand Partnership into ENT (June 2026) Building on their earlier robotics collaboration, Medtronic and Karl Storz announced a new strategic partnership to expand access to integrated ENT surgical solutions through the Medtronic AiBLE ecosystem.
Medtronic to Acquire SPR Therapeutics (~$650M, May 2026) Medtronic announced plans to acquire the developer of percutaneous peripheral nerve stimulation therapies for chronic pain, its third tuck-in acquisition of the year.
Jason Weidman Departs for Teleflex CEO Role (April 2026) Medtronic's SVP and President of Coronary & Renal Denervation, Jason Weidman, was named the new President and CEO of Teleflex, effective June 2026, one of several notable MedTech executive moves this year with Medtronic ties.
Medtronic Completes CathWorks Acquisition ($585M, April 2026) Following a 2022 strategic partnership, Medtronic completed its acquisition of CathWorks, adding the AI-powered FFRangio coronary artery disease diagnostic platform to its cardiovascular portfolio.
Medtronic to Acquire Scientia Vascular ($550M, March 2026) Medtronic agreed to acquire the neurovascular device maker, adding guidewires and catheters used in complex stroke and aneurysm procedures to its neurovascular portfolio.
MiniMed IPO and Diabetes Business Separation (February-March 2026) Medtronic's diabetes business, rebranded MiniMed, priced its IPO on March 5, 2026, raising roughly $560 million as the first step in fully separating from Medtronic, creating a standalone competitor to Dexcom, Insulet, and Tandem.
Medtronic Deal History
Medtronic Receives FDA Clearance for Hugo RAS System (December 2025) The FDA cleared Medtronic's Hugo robotic-assisted surgery system for urologic procedures, its first U.S. regulatory approval for the soft-tissue surgical robot and a major step toward directly competing with Intuitive Surgical's da Vinci platform.
Medtronic Announces Intent to Separate Diabetes Business (May 2025) Medtronic announced plans to spin off its Diabetes business into a standalone company, later named MiniMed, aiming to sharpen focus on higher-margin segments while creating an independent, direct-to-consumer diabetes competitor. This set the stage for the MiniMed IPO that priced in March 2026.
Medtronic Wins FDA Approval for Affera Mapping and Ablation System with Sphere-9 Catheter (October 2024) The approval made Medtronic the first and only company with two pulsed field ablation technologies on the market, adding an all-in-one mapping and dual-energy ablation catheter to its atrial fibrillation portfolio.
Medtronic Exits Ventilator Business, Forms Acute Care and Monitoring Unit (February 2024) Medtronic reversed a planned spinoff of its patient monitoring and respiratory interventions businesses, choosing instead to retain most of them while discontinuing its ventilator line and combining the remaining units into a new Acute Care and Monitoring segment.
Medtronic Wins FDA Approval for PulseSelect Pulsed Field Ablation System (December 2023) Medtronic became the first company to win U.S. approval for pulsed field ablation, a non-thermal technology to treat atrial fibrillation, beating rivals Boston Scientific and Johnson & Johnson to market.
Medtronic Wins FDA Approval for Symplicity Spyral Renal Denervation System (November 2023) After more than a decade of development dating back to Medtronic's 2011 acquisition of Ardian, the FDA approved Symplicity Spyral to treat hypertension, becoming one of only two approved renal denervation devices in the U.S.
Medtronic Wins FDA Approval for Expanded Conduction System Pacing Labeling (October 2022) Medtronic became the first and only company with therapies approved for conduction system pacing, an approach that more closely mimics the heart's natural electrical activity than traditional pacing.
Medtronic Acquires Affera ($925M, January 2022) Medtronic acquired Affera, adding a cardiac mapping and ablation platform to its electrophysiology business, a strategic move into pulsed field ablation ahead of the fast-growing atrial fibrillation treatment market.
Medtronic's Hugo RAS System Receives European CE Mark Approval (October 2021) Medtronic won CE Mark for its Hugo robotic-assisted surgery system in Europe, a major milestone in its bid to challenge Intuitive Surgical's dominance in soft-tissue robotic surgery.
Medtronic Completes Acquisition of Intersect ENT (~$1.1B, August 2021) Medtronic's largest acquisition in five years at the time, adding Intersect ENT's drug-eluting sinus implants and expanding its ear, nose, and throat portfolio.
Medtronic Completes Acquisition of Medicrea (November 2020) Medtronic completed its tender offer for the French AI-driven spinal surgery company, becoming the first company to offer an integrated AI-planning, personalized-implant, and robotic-surgery solution for spine.
Medtronic to Acquire Companion Medical (August 2020) Medtronic announced plans to acquire the maker of InPen, the only FDA-cleared smart insulin pen system on the market, building on its earlier Nutrino and Klue acquisitions in diabetes data.
Medtronic Acquires Digital Surgery (February 2020) Medtronic bought the London-based surgical AI and data analytics pioneer (maker of Touch Surgery) to bolster its Hugo robotic-assisted surgery platform with AI-driven education and analytics tools.
Medtronic Acquires Stimgenics (January 2020) A tuck-in acquisition of the Illinois-based spinal cord stimulation startup, adding a novel waveform technology to Medtronic's Intellis neurostimulator for chronic pain.
Medtronic Reveals Four-Year Karl Storz Partnership (June 2019) Ahead of unveiling its Hugo robotic-assisted surgery platform, Medtronic disclosed a previously undisclosed four-year collaboration with Karl Storz to integrate 3D vision systems into its robotics platform.
Q3 Medical Devices Signs Distribution Deal for Biodegradable Stent (May 2019) Medtronic's Gastrointestinal and Hepatology business signed a six-year exclusive deal to distribute Q3 Medical's ARCHIMEDES biodegradable biliary and pancreatic stent across the EU, U.S., and Japan.
Medtronic Launches Mazor X Stealth Edition in the U.S. (January 2019) Just weeks after the Mazor acquisition closed, Medtronic launched the co-developed Mazor X Stealth Edition, combining its StealthStation navigation with Mazor's robotic guidance, first used at Norton Healthcare and Reston Hospital Center.
Medtronic Completes Acquisition of Mazor Robotics (December 2018) One of Medtronic's largest deals of the decade: a $1.64-1.7 billion acquisition of the Israeli robotic spine surgery company, positioning Medtronic as the first company to offer an integrated AI-planning, robotics, and navigation solution for spine.
Medtronic to Acquire Nutrino Health (November 2018) Medtronic signed a deal for the Israeli nutrition-data and AI company, adding food analysis and glycemic-response prediction technology to its diabetes portfolio.
Medtronic Wins FDA Approval for Claria MRI Quad CRT-D (November 2016) The company received approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator, the first CRT-D to combine full MRI compatibility with its EffectivCRT algorithm for personalized pacing.
Medtronic Presents Positive Stress-Test Data for Micra Leadless Pacemaker (May 2016) A month after Micra, the first leadless, transcatheter pacemaker approved in the U.S., received FDA approval, Medtronic shared data showing consistent performance under maximal exertion treadmill testing.
Medtronic Announces Galway, Ireland Manufacturing Facility (December 2015) Medtronic announced a new manufacturing facility in Galway to produce its IN.PACT Admiral drug-coated balloon. (Note: the original headline cited "£95M"; the actual investment reported was €13 million/$14.3 million. Worth using the correct figure in the refreshed version.)
Medtronic Launches Arc Support Catheter for Solitaire Stent (September 2015) The company launched a new delivery catheter designed to improve navigation of its Solitaire stent retriever, used to physically remove clots in acute ischemic stroke patients.
Medtronic Acquires Twelve, Inc. (August 2015) Medtronic agreed to pay up to $458 million for the California-based developer of a transcatheter mitral valve replacement (TMVR) device, a bet on a device that, at the time, hadn't yet sold a single unit.
Medtronic Makes Several Acquisitions Post-Covidien Merger (mid-2015) Months after closing its $49.9 billion Covidien merger, Medtronic kept dealmaking, picking up CardioInsight Technologies (~$93M) and Aptus Endosystems (~$110M) in the same week, part of a broader push to buy early-stage U.S. technology.
Medtronic Launches Tyrx Antibacterial Envelope in Europe (September 2014) Fresh off its acquisition of Tyrx, Medtronic won CE Mark approval and launched the absorbable antibacterial envelope in Europe, a mesh that wraps around cardiac implants like pacemakers and ICDs to reduce surgical-site infections.
Medtronic Acquires Sapiens Steering Brain Stimulation (August 2014) Medtronic paid roughly $200 million for the Dutch developer of next-generation deep brain stimulation (DBS) technology, adding an advanced 40-point stimulation lead to its neuromodulation pipeline for Parkinson's and other neurodegenerative conditions.
This page is updated on a monthly basis to reflect Medtronic's ongoing activity. For a full history of Medtronic's involvement in a specific deal, [see our Medtech M&A Tracker] / [see our Medtech Funding Tracker].
